Roche CEO: We’ll See Continued Pressure on Drug Prices

The transcript discusses Roche's approach to healthcare policy changes, focusing on maintaining their mission to deliver transformational medicines. It covers strategies for differentiating medicines, adapting to drug pricing pressures, and ensuring transparency in pricing. The discussion also highlights Roche's efforts in personalized healthcare, indication-based pricing in Europe, and their strategic focus on innovation and acquisitions to maintain leadership in cancer and other therapeutic areas.

What are the key areas of focus for the company in terms of patient care?

How does the company view its role in the overall healthcare system?

What strategies does the company employ to ensure it remains a leader in cancer medicine?